Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Ongoing healthy habits: Even in the maintenance phase, its essential to continue practicing healthy habits, including a balanced diet and regular physical activity
The better option depends on BMI, weight-related health conditions, appetite patterns, insulin sensitivity, medical history, medication tolerance and provider recommendation
No surprise charges at checkout
acquired cardiometabolic-focused biotech assets via multi-billion oncology/metabolic expansion strategy, part of broader diabetes-obesity pipeline strengthening wave 2026: AstraZeneca expanded diabetes-obesity portfolio via multi-billion-dollar licensing and acquisition-style deal with CSPC Pharmaceuticals for GLP-1 class and metabolic drug programs targeting type 2 diabetes pipelines Request Strategic Market Customization: Japan: Recent Industry Developments March 2026: Takeda Pharmaceutical Company advanced its metabolic disease pipeline, focusing on innovative treatment approaches for type 2 diabetes and related complications
